Our company
A collective research center supporting human and animal healthIdeally located within the Walloon Biotech network, CER Groupe provides companies, universities, institutions and individuals with high quality services in the life sciences and agricultural sectors.
The group stands out by providing an end-to-end, pre-clinical solution in a regulated environment (ISO, GxP) and helping innovative companies to incubate, grow and take off in Belgium and abroad.
CER Groupe is a collective research center supporting human and animal health by providing products, research and services to companies active in the biotech, pharma, food safety and agriculture sectors.
High-quality services
The group manufactures innovative products and delivers polyclonal and monoclonal antibodies, diagnostic kits, reagents, as well as recombinant proteins and viruses to the pharmaceutical and food industries.
Recognized for its expertise and high-quality services, the group contributes to the agricultural economic development supporting the Walloon Region Agriculture Policies and Europe’s Common Agricultural Policy.
Key figures
Creation in 1977
+ 200 People
+ 60 Researchers
15,000 m2 operational facilities
CER Groupe and its subsidiaries
The CER Groupe incorporates four subsidiaries :
- Thymolux: GMP production of therapeutic antibodies for the pharmaceutical industry
- ECI (European Colostrum Industry): leader in the European colostrum market for feed, petfood and the food sector
- PFL (Pig For Life): a biotech company developing a disruptive xenograft-based diabetes treatment and your partner for pig model studies
- Agrinew : a non-profit organization promoting and enhancing the value of products from Walloon agriculture, particularly through processing workshops.
Together with the central CER Groupe's activities, the subsidiaries provide complementary technological areas to support the group's mission in contributing to animal and human health.